Severe Dysphagia is Rare After Magnetic Sphincter Augmentation.
Journal
World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
accepted:
11
04
2022
pubmed:
30
4
2022
medline:
2
8
2022
entrez:
29
4
2022
Statut:
ppublish
Résumé
Dysphagia remains the most significant concern after anti-reflux surgery, including magnetic sphincter augmentation (MSA). The aim of this study was to evaluate postoperative dysphagia rates, its risk factors, and management after MSA. From a prospectively collected database of all 357 patients that underwent MSA at our institution, a total of 268 patients were included in our retrospective study. Postoperative dysphagia score, gastrointestinal symptoms, proton pump inhibitor intake, GERD-HRQL, Alimentary Satisfaction, and serial contrast swallow imaging were evaluated within standardized follow-up appointments. To determine patients' characteristics and surgical factors associated with postoperative dysphagia, a multivariable logistic regression analysis was performed. At a median follow-up of 23 months, none of the patients presented with severe dysphagia, defined as the inability to swallow solids or/and liquids. 1% of the patients underwent endoscopic dilatation, and 1% had been treated conservatively for dysphagia. 2% of the patients needed re-operation, most commonly due to recurrent hiatal hernia. Two patients underwent device removal due to unspecific discomfort and pain. No migration of the device or erosion by the device was seen. The LINX® device size ≤ 13 was found to be the only factor associated with postoperative dysphagia (OR 5.90 (95% CI 1.4-24.8)). The postoperative total GERD-HRQL score was significantly lower than preoperative total score (2 vs. 19; p = 0.001), and daily heartburn, regurgitations, and respiratory complains improved in 228/241 (95%), 131/138 (95%) and 92/97 (95%) of patients, respectively. Dysphagia requiring endoscopic or surgical intervention was rare after MSA in a large case series. LINX® devices with a size < 13 were shown to be an independent risk factor for developing postoperative dysphagia.
Sections du résumé
BACKGROUND
Dysphagia remains the most significant concern after anti-reflux surgery, including magnetic sphincter augmentation (MSA). The aim of this study was to evaluate postoperative dysphagia rates, its risk factors, and management after MSA.
METHODS
From a prospectively collected database of all 357 patients that underwent MSA at our institution, a total of 268 patients were included in our retrospective study. Postoperative dysphagia score, gastrointestinal symptoms, proton pump inhibitor intake, GERD-HRQL, Alimentary Satisfaction, and serial contrast swallow imaging were evaluated within standardized follow-up appointments. To determine patients' characteristics and surgical factors associated with postoperative dysphagia, a multivariable logistic regression analysis was performed.
RESULTS
At a median follow-up of 23 months, none of the patients presented with severe dysphagia, defined as the inability to swallow solids or/and liquids. 1% of the patients underwent endoscopic dilatation, and 1% had been treated conservatively for dysphagia. 2% of the patients needed re-operation, most commonly due to recurrent hiatal hernia. Two patients underwent device removal due to unspecific discomfort and pain. No migration of the device or erosion by the device was seen. The LINX® device size ≤ 13 was found to be the only factor associated with postoperative dysphagia (OR 5.90 (95% CI 1.4-24.8)). The postoperative total GERD-HRQL score was significantly lower than preoperative total score (2 vs. 19; p = 0.001), and daily heartburn, regurgitations, and respiratory complains improved in 228/241 (95%), 131/138 (95%) and 92/97 (95%) of patients, respectively.
CONCLUSIONS
Dysphagia requiring endoscopic or surgical intervention was rare after MSA in a large case series. LINX® devices with a size < 13 were shown to be an independent risk factor for developing postoperative dysphagia.
Identifiants
pubmed: 35486162
doi: 10.1007/s00268-022-06573-2
pii: 10.1007/s00268-022-06573-2
pmc: PMC9334408
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2243-2250Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022. The Author(s).
Références
Danilova DA, Bazaev AV, Gorbunova LI (2020) Current aspects of surgical treatment of gastro-esophageal reflux disease. Khirurgiia (Mosk) 2:89–94
Schizas D, Mastoraki A, Papoutsi E, Giannakoulis VG, Kanavidis P, Tsilimigras D, Ntourakis D, Lyros O, Liakakos T, Moris D (2020) LINX((R)) reflux management system to bridge the “treatment gap” in gastroesophageal reflux disease: a systematic review of 35 studies. World J Clin Cases 8(2):294–305
doi: 10.12998/wjcc.v8.i2.294
Yamasaki T, Hemond C, Eisa M, Ganocy S, Fass R (2018) The changing epidemiology of gastroesophageal reflux disease: are patients getting younger? J Neurogastroenterol Motil 24(4):559–569
doi: 10.5056/jnm18140
Kulinna-Cosentini C, Arnoldner MA, Kristo I, Jomrich G, Schima W, Riegler M, Schoppmann SF, Cosentini EP (2019) Swallowing MRI for GERD—diagnosis and treatment monitoring. Eur Surg 51(5):231–238
doi: 10.1007/s10353-019-0601-1
Nikolic M, Schwameis K, Paireder M, Kristo I, Semmler G, Semmler L, Steindl A, Mosleh BO, Schoppmann SF (2019) Tailored modern GERD therapy—steps towards the development of an aid to guide personalized anti-reflux surgery. Sci Rep 9(1):19174
doi: 10.1038/s41598-019-55510-2
Falk GL, Gooley SC, Church NG, Rangiah DS (2020) How effective is the control of laryngopharyngeal reflux symptoms by fundoplication? Symptom score analysis. European Surgery 52(3):123–126
doi: 10.1007/s10353-020-00632-5
Falk GL, Archer L, Gooley SC (2020) Is fundoplication advisable in repair of para-oesophageal hernia? “Little operation” or “big operation”? Eur Surg 52(6):277–281
doi: 10.1007/s10353-020-00652-1
Moore M, Afaneh C, Benhuri D, Antonacci C, Abelson J, Zarnegar R (2016) Gastroesophageal reflux disease: A review of surgical decision making. World J Gastrointest Surg 8(1):77–83
doi: 10.4240/wjgs.v8.i1.77
Reynolds JL, Zehetner J, Wu P, Shah S, Bildzukewicz N, Lipham JC (2015) Laparoscopic magnetic sphincter augmentation vs laparoscopic Nissen fundoplication: a matched-pair analysis of 100 patients. J Am Coll Surg 221(1):123–128
doi: 10.1016/j.jamcollsurg.2015.02.025
Asti E, Aiolfi A, Lazzari V, Sironi A, Porta M, Bonavina L (2018) Magnetic sphincter augmentation for gastroesophageal reflux disease: review of clinical studies. Updates Surg 70(3):323–330
doi: 10.1007/s13304-018-0569-6
Falk GL, D’Netto TJ, Little SC (2019) Endoscopic atlas of fundoplication. Eur Surg 52(1):48–52
doi: 10.1007/s10353-019-00615-1
Wang YR, Dempsey DT, Richter JE (2011) Trends and perioperative outcomes of inpatient antireflux surgery in the United States, 1993–2006. Dis Esophagus 24(4):215–223
doi: 10.1111/j.1442-2050.2010.01123.x
Richter JE (2013) Gastroesophageal reflux disease treatment: side effects and complications of fundoplication. Clin Gastroenterol Hepatol 11(5):465–471; quiz e439.
Khan F, Maradey-Romero C, Ganocy S, Frazier R, Fass R (2016) Utilisation of surgical fundoplication for patients with gastro-oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013. Aliment Pharmacol Ther 43(11):1124–1131
doi: 10.1111/apt.13611
Yadlapati R, Hungness ES, Pandolfino JE (2018) Complications of antireflux surgery. Am J Gastroenterol 113(8):1137–1147
doi: 10.1038/s41395-018-0115-7
Schwameis K, Nikolic M, Castellano DGM, Steindl A, Macheck S, Riegler M, Kristo I, Zorner B, Schoppmann SF (2018) Crural closure improves outcomes of magnetic sphincter augmentation in GERD patients with Hiatal hernia. Sci Rep 8(1):7319
doi: 10.1038/s41598-018-24322-1
Bell R, Lipham J, Louie B, Williams V, Luketich J, Hill M, Richards W, Dunst C, Lister D, McDowell-Jacobs L et al (2019) Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial. Gastrointestinal Endoscopy 89(1):14–22 e11.
Buckley FP, Havemann B, Chawla A (2019) Magnetic sphincter augmentation: optimal patient selection and referral care pathways. World J Gastrointest Endosc 11(8):472–476
doi: 10.4253/wjge.v11.i8.443
Schwameis K, Nikolic M, Morales Castellano DG, Steindl A, Macheck S, Kristo I, Zorner B, Schoppmann SF (2018) Results of magnetic sphincter augmentation for gastroesophageal reflux disease. World J Surg. https://doi.org/10.1007/s00268-018-4608-8 .
Bonavina L, Saino G, Lipham JC, Demeester TR (2013) LINX((R)) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux. Therap Adv Gastroenterol 6(4):261–268
doi: 10.1177/1756283X13486311
Zadeh J, Andreoni A, Treitl D, Ben-David K (2018) Spotlight on the Linx Reflux Management System for the treatment of gastroesophageal reflux disease: evidence and research. Med Devices (Auckl) 11:291–300
Ganz RA, Edmundowicz SA, Taiganides PA, Lipham JC, Smith CD, DeVault KR, Horgan S, Jacobsen G, Luketich JD, Smith CC et al (2016) LLong-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux. Clin Gastroenterol Hepatol 14(5):671–677
doi: 10.1016/j.cgh.2015.05.028
Reynolds JL, Zehetner J, Bildzukewicz N, Katkhouda N, Dandekar G, Lipham JC (2014) Magnetic sphincter augmentation with the LINX device for gastroesophageal reflux disease after U.S. Food and Drug Administration approval. Am Surg 80(10):1034–1038.
Ayazi S, Zheng P, Zaidi AH, Chovanec K, Chowdhury N, Salvitti M, Komatsu Y, Omstead AN, Hoppo T, Jobe BA (2020) Magnetic sphincter augmentation and postoperative dysphagia: characterization, clinical risk factors, and management. J Gastrointest Surg 24(1):39–49
doi: 10.1007/s11605-019-04331-9
Tsai C, Steffen R, Kessler U, Merki H, Lipham J, Zehetner J (2020) Postoperative dysphagia following magnetic sphincter augmentation for gastroesophageal reflux disease. Surg Laparosc Endosc Percutan Tech 30(4):322–326
doi: 10.1097/SLE.0000000000000785
Bonavina L, Saino G, Bona D, Sironi A, Lazzari V (2013) One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center. J Am Coll Surg 217(4):577–585
doi: 10.1016/j.jamcollsurg.2013.04.039
Saeed ZA, Winchester CB, Ferro PS, Michaletz PA, Schwartz JT, Graham DY (1995) Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons for dilation of peptic strictures of the esophagus. Gastrointest Endosc 41(3):189–195
doi: 10.1016/S0016-5107(95)70336-5
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213
doi: 10.1097/01.sla.0000133083.54934.ae
Seabold S, Perktold J (2010) Statsmodels: econometric and statistical modeling with python. In: Proceedings of the 9th Python in Science Conference. Python in Science Conference
Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, Cournapeau D, Burovski E, Peterson P, Weckesser W, Bright J et al (2020) SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods 17(3):261–272.
Ferrari D, Asti E, Lazzari V, Siboni S, Bernardi D, Bonavina L (2020) Six to 12-year outcomes of magnetic sphincter augmentation for gastroesophageal reflux disease. Sci Rep 10(1):13753
doi: 10.1038/s41598-020-70742-3
Tatum JM, Alicuben E, Bildzukewicz N, Samakar K, Houghton CC, Lipham JC (2019) Removing the magnetic sphincter augmentation device: operative management and outcomes. Surg Endosc 33(8):2663–2669
doi: 10.1007/s00464-018-6544-y
Lipham JC, Taiganides PA, Louie BE, Ganz RA, DeMeester TR (2015) Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease. Dis Esophagus 28(4):305–311
doi: 10.1111/dote.12199
Bonavina L, Horbach T, Schoppmann SF, DeMarchi J (2020) Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication. Surg Endosc.